Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

United States In Situ Hybridization Market Report 2016

  • QYR673180
  • 116 Pages
  • September 2016
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of In Situ Hybridization

Revenue, means the sales value of In Situ Hybridization

This report studies sales (consumption) of In Situ Hybridization in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Abbott Molecular (USA)

Affymetrix, Inc. (USA)

Beckman Coulter, Inc. (USA)

Becton, Dickinson and Company (USA)

bioMerieux (France)

F. Hoffmann-La Roche Ltd. (Switzerland)

GE Healthcare Life Sciences (UK)

Luminex Corporation (USA)

QIAGEN N.V. (Netherlands)

Siemens Healthineers (Germany)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of In Situ Hybridization in each application, can be divided into

Medical care

Experiment

Application 3

Table of Contents

United States In Situ Hybridization Market Report 2016

1 In Situ Hybridization Overview

1.1 Product Overview and Scope of In Situ Hybridization

1.2 Classification of In Situ Hybridization

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of In Situ Hybridization

1.3.1 Medical care

1.3.2 Experiment

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of In Situ Hybridization (2011-2021)

1.4.1 USA In Situ Hybridization Sales and Growth Rate (2011-2021)

1.4.2 USA In Situ Hybridization Revenue and Growth Rate (2011-2021)

2 USA In Situ Hybridization Competition by Manufacturers

2.1 USA In Situ Hybridization Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA In Situ Hybridization Revenue and Share by Manufactures (2015 and 2016)

2.3 USA In Situ Hybridization Average Price by Manufactures (2015 and 2016)

2.4 In Situ Hybridization Market Competitive Situation and Trends

2.4.1 In Situ Hybridization Market Concentration Rate

2.4.2 In Situ Hybridization Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA In Situ Hybridization Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA In Situ Hybridization Sales and Market Share by Type (2011-2016)

3.2 USA In Situ Hybridization Revenue and Market Share by Type (2011-2016)

3.3 USA In Situ Hybridization Price by Type (2011-2016)

3.4 USA In Situ Hybridization Sales Growth Rate by Type (2011-2016)

4 USA In Situ Hybridization Sales (Volume) by Application (2011-2016)

4.1 USA In Situ Hybridization Sales and Market Share by Application (2011-2016)

4.2 USA In Situ Hybridization Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA In Situ Hybridization Manufacturers Profiles/Analysis

5.1 Abbott Molecular (USA)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 In Situ Hybridization Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Abbott Molecular (USA) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Affymetrix, Inc. (USA)

5.2.2 In Situ Hybridization Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Affymetrix, Inc. (USA) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Beckman Coulter, Inc. (USA)

5.3.2 In Situ Hybridization Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Beckman Coulter, Inc. (USA) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Becton, Dickinson and Company (USA)

5.4.2 In Situ Hybridization Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Becton, Dickinson and Company (USA) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 bioMerieux (France)

5.5.2 In Situ Hybridization Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 bioMerieux (France) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 F. Hoffmann-La Roche Ltd. (Switzerland)

5.6.2 In Situ Hybridization Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 F. Hoffmann-La Roche Ltd. (Switzerland) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 GE Healthcare Life Sciences (UK)

5.7.2 In Situ Hybridization Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 GE Healthcare Life Sciences (UK) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Luminex Corporation (USA)

5.8.2 In Situ Hybridization Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Luminex Corporation (USA) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 QIAGEN N.V. (Netherlands)

5.9.2 In Situ Hybridization Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 QIAGEN N.V. (Netherlands) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Siemens Healthineers (Germany)

5.10.2 In Situ Hybridization Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Siemens Healthineers (Germany) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

6 In Situ Hybridization Manufacturing Cost Analysis

6.1 In Situ Hybridization Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of In Situ Hybridization

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 In Situ Hybridization Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of In Situ Hybridization Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA In Situ Hybridization Market Forecast (2016-2021)

10.1 USA In Situ Hybridization Sales, Revenue Forecast (2016-2021)

10.2 USA In Situ Hybridization Sales Forecast by Type (2016-2021)

10.3 USA In Situ Hybridization Sales Forecast by Application (2016-2021)

10.4 In Situ Hybridization Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of In Situ Hybridization

Table Classification of In Situ Hybridization

Figure USA Sales Market Share of In Situ Hybridization by Type in 2015

Table Application of In Situ Hybridization

Figure USA Sales Market Share of In Situ Hybridization by Application in 2015

Figure Medical care Examples

Figure Experiment Examples

Figure USA In Situ Hybridization Sales and Growth Rate (2011-2021)

Figure USA In Situ Hybridization Revenue and Growth Rate (2011-2021)

Table USA In Situ Hybridization Sales of Key Manufacturers (2015 and 2016)

Table USA In Situ Hybridization Sales Share by Manufacturers (2015 and 2016)

Figure 2015 In Situ Hybridization Sales Share by Manufacturers

Figure 2016 In Situ Hybridization Sales Share by Manufacturers

Table USA In Situ Hybridization Revenue by Manufacturers (2015 and 2016)

Table USA In Situ Hybridization Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA In Situ Hybridization Revenue Share by Manufacturers

Table 2016 USA In Situ Hybridization Revenue Share by Manufacturers

Table USA Market In Situ Hybridization Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market In Situ Hybridization Average Price of Key Manufacturers in 2015

Figure In Situ Hybridization Market Share of Top 3 Manufacturers

Figure In Situ Hybridization Market Share of Top 5 Manufacturers

Table USA In Situ Hybridization Sales by Type (2011-2016)

Table USA In Situ Hybridization Sales Share by Type (2011-2016)

Figure USA In Situ Hybridization Sales Market Share by Type in 2015

Table USA In Situ Hybridization Revenue and Market Share by Type (2011-2016)

Table USA In Situ Hybridization Revenue Share by Type (2011-2016)

Figure Revenue Market Share of In Situ Hybridization by Type (2011-2016)

Table USA In Situ Hybridization Price by Type (2011-2016)

Figure USA In Situ Hybridization Sales Growth Rate by Type (2011-2016)

Table USA In Situ Hybridization Sales by Application (2011-2016)

Table USA In Situ Hybridization Sales Market Share by Application (2011-2016)

Figure USA In Situ Hybridization Sales Market Share by Application in 2015

Table USA In Situ Hybridization Sales Growth Rate by Application (2011-2016)

Figure USA In Situ Hybridization Sales Growth Rate by Application (2011-2016)

Table Abbott Molecular (USA) Basic Information List

Table Abbott Molecular (USA) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Abbott Molecular (USA) In Situ Hybridization Sales Market Share (2011-2016)

Table Affymetrix, Inc. (USA) Basic Information List

Table Affymetrix, Inc. (USA) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

Table Affymetrix, Inc. (USA) In Situ Hybridization Sales Market Share (2011-2016)

Table Beckman Coulter, Inc. (USA) Basic Information List

Table Beckman Coulter, Inc. (USA) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

Table Beckman Coulter, Inc. (USA) In Situ Hybridization Sales Market Share (2011-2016)

Table Becton, Dickinson and Company (USA) Basic Information List

Table Becton, Dickinson and Company (USA) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

Table Becton, Dickinson and Company (USA) In Situ Hybridization Sales Market Share (2011-2016)

Table bioMerieux (France) Basic Information List

Table bioMerieux (France) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

Table bioMerieux (France) In Situ Hybridization Sales Market Share (2011-2016)

Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List

Table F. Hoffmann-La Roche Ltd. (Switzerland) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

Table F. Hoffmann-La Roche Ltd. (Switzerland) In Situ Hybridization Sales Market Share (2011-2016)

Table GE Healthcare Life Sciences (UK) Basic Information List

Table GE Healthcare Life Sciences (UK) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

Table GE Healthcare Life Sciences (UK) In Situ Hybridization Sales Market Share (2011-2016)

Table Luminex Corporation (USA) Basic Information List

Table Luminex Corporation (USA) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

Table Luminex Corporation (USA) In Situ Hybridization Sales Market Share (2011-2016)

Table QIAGEN N.V. (Netherlands) Basic Information List

Table QIAGEN N.V. (Netherlands) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

Table QIAGEN N.V. (Netherlands) In Situ Hybridization Sales Market Share (2011-2016)

Table Siemens Healthineers (Germany) Basic Information List

Table Siemens Healthineers (Germany) In Situ Hybridization Sales, Revenue, Price and Gross Margin (2011-2016)

Table Siemens Healthineers (Germany) In Situ Hybridization Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of In Situ Hybridization

Figure Manufacturing Process Analysis of In Situ Hybridization

Figure In Situ Hybridization Industrial Chain Analysis

Table Raw Materials Sources of In Situ Hybridization Major Manufacturers in 2015

Table Major Buyers of In Situ Hybridization

Table Distributors/Traders List

Figure USA In Situ Hybridization Production and Growth Rate Forecast (2016-2021)

Figure USA In Situ Hybridization Revenue and Growth Rate Forecast (2016-2021)

Table USA In Situ Hybridization Production Forecast by Type (2016-2021)

Table USA In Situ Hybridization Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370
DNA Sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...

  • Publish Date: May 24, 2017
  • $5370